Skip to main content

Advertisement

SpringerLink
Log in

Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Lunn MPT, Manji H, Choudhary PP, Hughes RAC, Thomas PK (1999) Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66:677–680

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS (2015) Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry 86(9):973–985

    Article  PubMed  PubMed Central  Google Scholar 

  3. Koller H, Kieseier B, Jander S, Hartung H (2005) Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352:1343–1356

    Article  PubMed  Google Scholar 

  4. Mahdi-Rogers M, van Doorn PA, Hughes RA (2013) Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev (6):CD003280

  5. European Federation of Neurological Societies/Peripheral Nerve Society (2010) Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society–First Revision. Joint Task Force of the EFNS and the PNS. J Peripher Nerv Syst 15(1):1–9

  6. Martinenghi S, Comi G, Galardi G, Di Carlo V, Pozza G, Secchi A (1997) Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas. Diabetologia 40(9):1110–1112

    Article  CAS  PubMed  Google Scholar 

  7. Stathopoulos P, Alexopoulos H, Dalakas MC (2015) Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders. Nat Rev Neurol. 11(3):143–156

    Article  CAS  PubMed  Google Scholar 

  8. Briani C, Zara G, Zambello R et al (2004) Rituximab-responsive CIDP. Eur J Neurol 11(788e):91

    Google Scholar 

  9. Knecht H, Baumberger M, Tobon A, Steck A (2004) Sustained remission of CIDP associated with Evans syndrome. Neurology 63(4):730–732

    Article  PubMed  Google Scholar 

  10. Benedetti L, Briani C, Franciotta D, Fazio R, Paolasso I, Comi C, Luigetti M, Sabatelli M, Giannini F, Mancardi GL, Schenone A, Nobile-Orazio E, Cocito D (2011) Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature. J Neurol Neurosurg Psychiatry 82(3):306–308

    Article  CAS  PubMed  Google Scholar 

  11. D’Amico A, Catteruccia M, De Benedetti F, Vivarelli M, Colucci M, Cascioli S, Bertini E (2012) Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy. Eur J Paediatr Neurol. 16(3):301–303

    Article  PubMed  Google Scholar 

  12. Sanz PG, García Méndez CV, Cueto AL, Silva VB, Walther JC, Diez RA, Martins S, Giannaula RJ (2012) Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment. Rheumatol Int 32(12):4061–4063

    Article  CAS  PubMed  Google Scholar 

  13. Ware TL, Kornberg AJ, Rodriguez-Casero MV, Ryan MM (2014) Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era. J Child Neurol 29(1):43–48

    Article  PubMed  Google Scholar 

  14. Querol L, Rojas-García R, Diaz-Manera J, Barcena J, Pardo J, Ortega-Moreno A, Sedano MJ, Seró-Ballesteros L, Carvajal A, Ortiz N, Gallardo E, Illa I (2015) Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm. 2(5):e149

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gorson KC, Natarajan N, Ropper AH, Weinstein R (2007) Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 35(1):66–69

    Article  CAS  PubMed  Google Scholar 

  16. Cocito D, Grimaldi S, Paolasso I, Falcone Y, Antonini G, Benedetti L, Briani C, Fazio R, Jann S, Matà S, Sabatelli M (2011) Nobile-Orazio E; Italian Network for CIDP Register. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol 18(12):1417–1421

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy

    Daniele Velardo, Nilo Riva, Giancarlo Comi & Raffaella Fazio

  2. Division of Neuroscience, Department of Neurophysiology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy

    Ubaldo Del Carro & Francesca Bianchi

Authors
  1. Daniele Velardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nilo Riva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ubaldo Del Carro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesca Bianchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giancarlo Comi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Raffaella Fazio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniele Velardo.

Ethics declarations

Conflicts of interest

None.

Ethical standard

All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Velardo, D., Riva, N., Del Carro, U. et al. Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases. J Neurol 264, 1011–1014 (2017). https://doi.org/10.1007/s00415-017-8462-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-017-8462-7

Keywords

Search

Navigation